NONE

Company

Terns Pharmaceuticals, Inc.

Filed

June 7, 2022

Accession Number

0001567619-22-012438

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →